Insider Selling: Organicell Regenerative Medicine, Inc. (OTCMKTS:BPSR) Major Shareholder Sells $49,000.00 in Stock

Organicell Regenerative Medicine, Inc. (OTCMKTS:BPSR) major shareholder Albert Mitrani sold 100,000 shares of the stock in a transaction on Friday, April 30th. The shares were sold at an average price of $0.49, for a total value of $49,000.00. Major shareholders that own 10% or more of a company’s stock are required to disclose their transactions with the SEC.

Shares of BPSR stock opened at $0.25 on Tuesday. The business has a fifty day moving average of $0.10 and a 200 day moving average of $0.12. Organicell Regenerative Medicine, Inc. has a 1 year low of $0.03 and a 1 year high of $0.63.

About Organicell Regenerative Medicine

Organicell Regenerative Medicine, Inc, a clinical-stage biopharmaceutical company, focuses on the development of biological therapeutics for the treatment of degenerative diseases. Its leading product candidate is Zofin, an acellular, biologic therapeutic derived from perinatal sources and is manufactured to retain naturally occurring microRNAs without the addition or combination of any other substance or diluent, which is in Phase I/II clinical trial to treat COVID-19.

Read More: What are no-load funds?

Receive News & Ratings for Organicell Regenerative Medicine Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Organicell Regenerative Medicine and related companies with MarketBeat.com's FREE daily email newsletter.